1. Home
  2. OFG vs OGN Comparison

OFG vs OGN Comparison

Compare OFG & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OFG Bancorp

OFG

OFG Bancorp

HOLD

Current Price

$45.96

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.32

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OFG
OGN
Founded
1964
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
OFG
OGN
Price
$45.96
$13.32
Analyst Decision
Buy
Sell
Analyst Count
6
4
Target Price
$45.17
$10.75
AVG Volume (30 Days)
212.3K
12.0M
Earning Date
04-21-2026
05-07-2026
Dividend Yield
3.05%
0.61%
EPS Growth
8.27
N/A
EPS
4.58
0.72
Revenue
N/A
$6,216,000,000.00
Revenue This Year
$11.56
$0.45
Revenue Next Year
$1.29
$1.67
P/E Ratio
$9.99
$18.27
Revenue Growth
N/A
N/A
52 Week Low
$35.71
$5.69
52 Week High
$46.85
$13.24

Technical Indicators

Market Signals
Indicator
OFG
OGN
Relative Strength Index (RSI) 71.40 79.55
Support Level $41.11 $6.31
Resistance Level N/A N/A
Average True Range (ATR) 1.07 0.72
MACD 0.31 0.52
Stochastic Oscillator 82.29 99.20

Price Performance

Historical Comparison
OFG
OGN

About OFG OFG Bancorp

OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: